文献速递脑血管病

同侧大脑中浅静脉未充盈与再灌注治疗不良预后相关

Absent Filling of Ipsilateral Superficial Middle Cerebral Vein Is Associated With Poor Outcome After Reperfusion Therapy.
PubMed 文献 · Stroke · 2017-03-06

本研究纳入228例接受静脉溶栓的缺血性卒中患者,利用4D CTA评估皮质静脉充盈。结果显示仅大脑中浅静脉未充盈(SMCV-)独立预测3个月不良预后(OR 2.710,P=0.040),尤其在未实现主要再灌注者中SMCV-与更大梗死体积、更高不良预后和死亡率相关,其不良效应主要与脑水肿相关。

要点

  • SMCV未充盈独立预测溶栓后3个月不良预后(OR 2.710,P=0.040)。
  • 未实现主要再灌注者中,SMCV-与更大24小时梗死体积、更高不良预后和死亡相关。
  • SMCV-与24小时脑水肿相关,脑水肿进而与3个月不良预后相关。

核心结论

  • 大脑中浅静脉未充盈导致溶栓后不良预后,尤其在未实现再灌注时。
  • 静脉充盈不良的主要有害效应似乎与脑水肿发生相关。

研究设计与样本

  • 连续纳入接受静脉溶栓的缺血性卒中患者,治疗前及溶栓后24小时行CT灌注或MR灌注。
  • 共纳入228例患者,通过4D CTA定义同侧皮质静脉未充盈为整个静脉期无对比剂充盈。

主要发现

  • 228例中SMCV-、Trolard静脉-和Labbé静脉-分别见于50例(21.9%)、27例(11.8%)和32例(14.0%)。
  • 仅SMCV-独立预测3个月改良Rankin量表评分>2(OR 2.710,P=0.040)。
  • SMCV-与未SMCV-患者治疗后再灌注率无差异(P>0.05)。
  • 实现主要再灌注(≥80%)者中,SMCV-与无SMCV-的24小时梗死体积及不良预后率无差异(P>0.05)。
  • 未实现主要再灌注者中,SMCV-患者较SMCV充盈患者24小时梗死体积更大(P=0.011)、不良预后率更高(P=0.012)、死亡率更高(P=0.032)。

临床怎么用

  • 对于接受静脉溶栓的缺血性卒中患者,可关注4D CTA上SMCV充盈情况以辅助预后评估。
  • SMCV未充盈且未实现主要再灌注的患者预后较差,需警惕脑水肿发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Our aim was to study the effect of drainage of cortical veins, including the superficial middle cerebral vein (SMCV), vein of Trolard, and vein of Labbé on neurological outcomes after reperfusion therapy. METHODS: Consecutive ischemic stroke patients who underwent pretreatment computed tomographic perfusion and 24-hour computed tomographic perfusion or magnetic resonance perfusion after intravenous thrombolysis were included. We defined "absent filling of ipsilateral cortical vein" (eg, SMCV-) as no contrast filling of the vein across the whole venous phase on 4-dimensional computed tomographic angiography in the ischemic hemisphere. RESULTS: Of 228 patients, SMCV-, vein of Trolard- and vein of Labbé- were observed in 50 (21.9%), 27 (11.8%), and 32 (14.0%) patients, respectively. Only SMCV- independently predicted poor outcome (3-month modified Rankin Scale score of >2; odds ratio, 2.710; P=0.040). No difference was found in reperfusion rate after treatment between patients with and without SMCV- (P>0.05). In patients achieving major reperfusion (≥80%), there was no difference in 24-hour infarct volume, or rate of poor outcome between patients with and without SMCV- (P>0.05). However, in those without major reperfusion, patients with SMCV- had larger 24-hour infarct volume (P=0.011), higher rate of poor outcome (P=0.012), and death (P=0.032) compared with those with SMCV filling. SMCV- was significantly associated with brain edema at 24 hours (P=0.037), which, in turn, was associated with poor 3-month outcome (P=0.002). CONCLUSIONS: Lack of SMCV filling contributed to poor outcome after thrombolysis, especially when reperfusion was not achieved. The main deleterious effect of poor venous filling appears related to the development of brain edema.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Zhang S, Lai Y, Ding X, et al. Absent Filling of Ipsilateral Superficial Middle Cerebral Vein Is Associated With Poor Outcome After Reperfusion Therapy. Stroke. 2017. PMID: 28265013. doi:10.1161/STROKEAHA.116.016174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。